When it comes to NSCLC, the methylation rate of MLH1 was reported as 27%–35.7%, whereas the incidence of MSI-H was rare (Seng et al., 2008; Pastuszak-Lewandoska et al., 2016). This evidence concerns the gene MLH1 and non-small cell lung carcinoma.